Literature DB >> 7715703

Targeted disruption of the tyrosine hydroxylase gene reveals that catecholamines are required for mouse fetal development.

Q Y Zhou1, C J Quaife, R D Palmiter.   

Abstract

Tyrosine hydroxylase catalyses the initial, rate-limiting step in the catecholamine biosynthetic pathway. Catecholamines, which include dopamine, noradrenaline, and adrenaline, are important neurotransmitters and hormones that regulate visceral functions, motor coordination and arousal in adults. The gene encoding tyrosine hydroxylase becomes transcriptionally active in developing neuroblasts during mid-gestation of rodent embryos, before the onset of neurotransmission. Here we show that inactivation of both tyrosine hydroxylase alleles results in mid-gestational lethality: about 90% of mutant embryos die between embryonic days 11.5 and 15.5, apparently of cardiovascular failure. Administration of L-DOPA (dihydroxyphenylalanine), the product of the tyrosine hydroxylase reaction, to pregnant females results in complete rescue of mutant mice in utero. Without further treatment, however, they die before weaning. We conclude that catecholamines are essential for mouse fetal development and postnatal survival.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7715703     DOI: 10.1038/374640a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  122 in total

1.  Modest neuropsychological deficits caused by reduced noradrenaline metabolism in mice heterozygous for a mutated tyrosine hydroxylase gene.

Authors:  K Kobayashi; Y Noda; N Matsushita; K Nishii; H Sawada; T Nagatsu; D Nakahara; R Fukabori; Y Yasoshima; T Yamamoto; M Miura; M Kano; T Mamiya; Y Miyamoto; T Nabeshima
Journal:  J Neurosci       Date:  2000-03-15       Impact factor: 6.167

Review 2.  Lessons learned from gene targeting and transgenesis for adrenal physiology and disease.

Authors:  A Böttner; S R Bornstein
Journal:  Rev Endocr Metab Disord       Date:  2001-08       Impact factor: 6.514

3.  Protein kinase-A dependent phosphorylation of transcription enhancer factor-1 represses its DNA-binding activity but enhances its gene activation ability.

Authors:  M P Gupta; P Kogut; M Gupta
Journal:  Nucleic Acids Res       Date:  2000-08-15       Impact factor: 16.971

Review 4.  Genetically engineered mouse models of Parkinson's disease.

Authors:  Donna M Crabtree; Jianhua Zhang
Journal:  Brain Res Bull       Date:  2011-08-03       Impact factor: 4.077

5.  Targeted disruption of the mouse beta1-adrenergic receptor gene: developmental and cardiovascular effects.

Authors:  D K Rohrer; K H Desai; J R Jasper; M E Stevens; D P Regula; G S Barsh; D Bernstein; B K Kobilka
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

6.  Study of a fetal brain affected by a severe form of tyrosine hydroxylase deficiency, a rare cause of early parkinsonism.

Authors:  Alba Tristán-Noguero; Héctor Díez; Cristina Jou; Mercè Pineda; Aida Ormazábal; Aurora Sánchez; Rafael Artuch; Àngels Garcia-Cazorla
Journal:  Metab Brain Dis       Date:  2015-12-21       Impact factor: 3.584

7.  Conserved Upstream Regulatory Regions in Mammalian Tyrosine Hydroxylase.

Authors:  Meng Wang; Lilah Fones; John W Cave
Journal:  Mol Neurobiol       Date:  2018-02-05       Impact factor: 5.590

8.  Increased FGF21 in brown adipose tissue of tyrosine hydroxylase heterozygous mice: implications for cold adaptation.

Authors:  Patricia Vázquez; Catalina Hernández-Sánchez; Carmen Escalona-Garrido; Laura Pereira; Cristina Contreras; Miguel López; Jesús Balsinde; Flora de Pablo; Ángela M Valverde
Journal:  J Lipid Res       Date:  2018-10-23       Impact factor: 5.922

9.  Netrin-1 controls sympathetic arterial innervation.

Authors:  Isabelle Brunet; Emma Gordon; Jinah Han; Brunella Cristofaro; Dong Broqueres-You; Chun Liu; Karine Bouvrée; Jiasheng Zhang; Raquel del Toro; Thomas Mathivet; Bruno Larrivée; Julia Jagu; Laurence Pibouin-Fragner; Luc Pardanaud; Maria J C Machado; Timothy E Kennedy; Zhen Zhuang; Michael Simons; Bernard I Levy; Marc Tessier-Lavigne; Almut Grenz; Holger Eltzschig; Anne Eichmann
Journal:  J Clin Invest       Date:  2014-06-17       Impact factor: 14.808

Review 10.  Tyrosine hydroxylase and Parkinson's disease.

Authors:  J Haavik; K Toska
Journal:  Mol Neurobiol       Date:  1998-06       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.